Efficacy, safety, and spatial transcriptomic rationale of orelabrutinib plus obinutuzumab in marginal zone lymphoma

ABSTRACT: This submission contains raw 10x Genomics Visium HD Spatial Gene Expression FASTQ files from three FFPE mucosa-associated lymphoid tissue lymphoma samples analyzed in the O2 marginal zone lymphoma study. Processed Space Ranger and downstream spatial transcriptomics files will be added before final GEO release. Submitter contact email: [e-mail].

ORGANISM(S): Homo sapiens

PROVIDER: GSE337521 | GEO | 2026/07/15

REPOSITORIES: GEO